GlassScriptPhysician profile
Joyce Yeung
NPI 1417203456
$15,484.95
in general payments reported to CMS, 2019-2025
29 companies · $3,057 in 2025
The $3,057 reported for 2025 was more than what 96% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,461 · 2022: $3,699 · 2023: $2,461 · 2024: $2,807 · 2025: $3,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,291 · Education: $19.62 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,290.56 |
| Education | $19.62 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,755.37 | 2021-2025 | Cyltezo, Jardiance, Ofev |
| Astrazeneca Pharmaceuticals LP | $2,295.87 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $1,960.19 | 2021-2025 | Evenity, Repatha, Prolia |
| Gilead Sciences, INC. | $1,715.59 | 2021-2025 | Livdelzi, Vemlidy |
| Esperion Therapeutics, INC. | $1,174.06 | 2021-2025 | Nexletol, Nexlizet |
| Glaxosmithkline, LLC. | $1,015.13 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amarin Pharma, INC. | $740.80 | 2021-2023 | |
| Lilly USA, LLC | $685.37 | 2021-2024 | Mounjaro, Zepbound, Emgality |
| Novo Nordisk INC | $571.39 | 2021-2025 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $566.85 | 2023-2025 | |
| Galderma Laboratories, L.P. | $471.01 | 2024-2025 | Nemluvio |
| Ibsa Pharma INC. | $404.28 | 2021-2024 | Tirosint, Tirosint, Licart |
| Sanofi-Aventis U.S. LLC | $204.12 | 2021-2022 | |
| Exact Sciences Corporation | $190.09 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $99.18 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $93.33 | 2023 | Ibsrela |
| Almatica Pharma LLC | $81.61 | 2024-2025 | Teriparatide, Loreev Xr |
| Kowa Pharmaceuticals America, INC. | $76.72 | 2021-2022 | |
| Radius Health, INC. | $67.85 | 2021-2025 | |
| Abbvie INC. | $55.47 | 2021 | |
| Merck Sharp & Dohme LLC | $52.62 | 2021-2022 | |
| Pfizer INC. | $44.71 | 2022 | |
| Nestle Healthcare Nutrition INC. | $34.68 | 2021-2022 | |
| Averitas Pharma INC. | $25.00 | 2023 | Qutenza |
| Phathom Pharmaceuticals, INC. | $24.54 | 2024 | Voquezna |
| Philips North America LLC | $22.73 | 2025 | Vest Therapy Und |
| Hikma Pharmaceuticals USA | $21.04 | 2022 | |
| Scilex Pharmaceuticals INC. | $20.45 | 2021 | |
| Medicure Pharma INC. | $14.90 | 2024 | Zypitamag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Yeung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.